Analyst Recommendations

Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for KGSPY on April 29, 2024 01:38PM ET. The previous analyst recommendation was Equal-Weight.KGSPY was trading at $90.51 at issue of the...

April 29, 2024   KGSPY -1.11%

Morgan Stanley analyst issues OVERWEIGHT recommendation for VCISY on April 29, 2024 01:47PM ET. The previous analyst recommendation was Overweight.VCISY was trading at $29.58 at issue of the...

April 29, 2024   VCISY -0.26%

RBC Capital analyst issues UNDERPERFORM recommendation for NOV on April 29, 2024 01:01PM ET. The previous analyst recommendation was Underperform.NOV was trading at $19.37 at issue of the...

April 29, 2024   NOV 4.72%

Susquehanna analyst issues SECTOR PERFORM recommendation for NOV on April 29, 2024 01:01PM ET. The previous analyst recommendation was Sector Perform.NOV was trading at $19.37 at issue of...

April 29, 2024   NOV 4.72%

Citigroup analyst issues BUY recommendation for CABA on April 29, 2024 12:01PM ET. The previous analyst recommendation was Buy.CABA was trading at $10.84 at issue of the analyst...

April 29, 2024   CABA 4.19%

BMO Capital analyst issues OUTPERFORM recommendation for EQX on April 29, 2024 10:50AM ET. The previous analyst recommendation was Outperform.EQX was trading at $5.6009 at issue of the...

April 29, 2024   EQX -2.67%

CIBC analyst issues NEUTRAL recommendation for WM on April 29, 2024 10:41AM ET. The previous analyst recommendation was Neutral.WM was trading at $211.7325 at issue of the analyst...

April 29, 2024   WM -1.04%

Scotiabank analyst issues OUTPERFORM recommendation for CNXC on April 29, 2024 09:29AM ET. The previous analyst recommendation was Outperform.CNXC was trading at $56.86 at issue of the analyst...

April 29, 2024   CNXC 2.14%

RBC Capital analyst issues OUTPERFORM recommendation for HCA on April 29, 2024 09:25AM ET. The previous analyst recommendation was Outperform.HCA was trading at $311.07 at issue of the...

April 29, 2024   HCA -0.67%

RBC Capital analyst issues OUTPERFORM recommendation for CHRD on April 29, 2024 09:37AM ET. The previous analyst recommendation was Outperform.CHRD was trading at $184.18 at issue of the...

April 29, 2024   CHRD 4.02%